NCT05586243 is a clinical trial of No intervention in Gaucher Disease, Type 3, sponsored by University of Minnesota.

Who is sponsoring NCT05586243?

NCT05586243 is sponsored by University of Minnesota.

What drugs are being tested in NCT05586243?

Interventions in NCT05586243: No intervention.

What condition does NCT05586243 study?

NCT05586243 studies Gaucher Disease, Type 3.

Is NCT05586243 still recruiting?

NCT05586243 is currently recruiting now. Last updated 8 January 2026.

Last reviewed 2026-01-08 · How we verify

NCT05586243

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Recruiting now Last updated 8 January 2026

What this trial tests

trial testing No intervention in Gaucher Disease, Type 3 in 5 participants. Currently enrolling.

Timeline

1 January 2023

Primary endpoint
31 July 2026

31 July 2026

Quick facts

Lead sponsor	University of Minnesota
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	5
Start date	1 January 2023
Primary completion	31 July 2026
Estimated completion	31 July 2026
Sites	1 location across United States

Drugs / interventions tested

No intervention

Conditions studied

Gaucher Disease, Type 3 — all drugs for Gaucher Disease, Type 3 →

Sponsor

University of Minnesota

Who can join

Adults 18 to 80, any sex, with Gaucher Disease, Type 3. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recent studies have has shown that magnetic resonance spectroscopy (MRS) can provide validated neuronal markers in patients with Type 1 GD (GD1) who are on stable therapy. However, alterations in neurometabolites in adult patients with GD3, who have established neurological involvement, are not well understood. The goal of this study is to characterize neurometabolite profiles in adult patients with GD3 using MRS to identify novel biomarkers that can demonstrate treatment response. Additionally, a secondary aim is to evaluate relationships between neurometabolites and disease parameters, such as genotype, enzyme levels and Gaucher disease (GD) biomarkers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Gaucher Disease, Type 3

Currently open trials in the same condition.

NCT04532047 — PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) · Phase 1 · recruiting

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05586243 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 8 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05586243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing